Author: Flare Therapeutics Inc.

Posted Date:

April 6, 2026

Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026

Flare Therapeutics Inc.

April 6, 2026
Flare Therapeutics Presents Updated FX-909 Phase 1A Data in Late-Breaking Oral Presentation at 2026 ASCO Genitourinary Cancers Symposium

Flare Therapeutics Inc.

February 27, 2026